{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:23:17Z","timestamp":1789669397090,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004317","name":"Shihezi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation for Postgraduate","doi-asserted-by":"publisher","award":["CX20240024"],"award-info":[{"award-number":["CX20240024"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571692"],"award-info":[{"award-number":["32571692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460597"],"award-info":[{"award-number":["82460597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.115009","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:29:50Z","timestamp":1778340590000},"page":"115009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Breaking the oncogene\u2013immune suppression cycle through dual HER2 silencing and innate immune activation by biomineralized DNA nanocomplexes"],"prefix":"10.1016","volume":"395","author":[{"given":"Yubei","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaige","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115009_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.115009_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.115009_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1776875","article-title":"Macrophage-associated prognostic modeling uncovers immunotherapy response mechanisms and defines HAGHL as a novel oncogenic driver in breast cancer","volume":"17","author":"Pei","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116466","article-title":"In situ preparation of MOF-199 into the carrageenan-grafted-polyacrylamide@Fe3O4 matrix for enhanced adsorption of levofloxacin and cefixime antibiotics from water","volume":"233","author":"Salehi","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.jconrel.2026.115009_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2025.136121","article-title":"A cleansing magnetic nanosystem made of Fe\/Zn\/MIL101-embedded Arabic gum rich of chlorophyllin: photodegradation of eriochrome black-T and pathogens in water media","volume":"709","author":"Kashtiaray","year":"2025","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.jconrel.2026.115009_bb0030","article-title":"Chlorpyrifos and diazinon elimination through pAAm-g-XG\/HKUST-1@Fe3O4 biopolymer nanoadsorbent hydrogel from wastewater: preparation, characterization, kinetics and isotherm","volume":"334","author":"Salehi","year":"2024","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144406","article-title":"Eco-friendly, magnetic NiFe\u2082O\u2084@sodium alginate-g-poly(3-aminophenol) nanocatalyst for synthesizing bioactive polyhydroquinolines with antioxidant, antibacterial, and anticancer properties","volume":"315","author":"Nezhad","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133189","article-title":"Magnetic carboxymethyl gond katira-grafted-poly(3-aminobenzoic acid) as an antibacterial biosorbent for purification of acetamiprid-contaminated water","volume":"273","author":"Mosavi","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0045","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1186\/s12889-026-27291-7","article-title":"Women\u2019s perceptions of breast cancer risk and prevention: insights into knowledge gaps and lifestyle attitudes","volume":"26","author":"Jonsson","year":"2026","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jconrel.2026.115009_bb0050","first-page":"605","article-title":"HER2-low breast cancer: current landscape and future prospects","volume":"15","author":"Shirman","year":"2023","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jconrel.2026.115009_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038508","article-title":"HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jconrel.2026.115009_bb0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","article-title":"PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies","volume":"23","author":"Jin","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.115009_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1470-2045(20)30536-2","article-title":"Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study","volume":"22","author":"Tan","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0070","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13046-024-03143-3","article-title":"The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overexpressing breast cancer","volume":"43","author":"Lee","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115009_bb0075","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1158\/0008-5472.CAN-23-4066","article-title":"Molecular characterization and classification of HER2-positive breast cancer inform tailored therapeutic strategies","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115009_bb0080","first-page":"1202","article-title":"p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2(+) breast cancer that limits trastuzumab deruxtecan efficacy","volume":"6","author":"Hu","year":"2025","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.115009_bb0085","article-title":"Resistance mechanisms and prospects of Trastuzumab","volume":"14","author":"Wang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12964-024-02023-9","article-title":"NK cell immunopotentiators-loaded nanoliposomes enhance ADCC effect for targeted therapy against HER2-positive breast cancer","volume":"23","author":"Du","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2026.115009_bb0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Bose","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.115009_bb0100","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1200\/JCO.20.00775","article-title":"Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial","volume":"38","author":"Lin","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0105","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1200\/JCO.20.00147","article-title":"Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with \u2265 2 HER2-directed regimens: phase III NALA trial","volume":"38","author":"Saura","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-020-0153-3","article-title":"Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond","volume":"6","author":"Costa","year":"2020","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.jconrel.2026.115009_bb0115","article-title":"The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation","volume":"43","author":"Firuzpour","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.jconrel.2026.115009_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107695","article-title":"Advances in HER2-targeted therapies: from monoclonal antibodies to dual inhibitors developments in cancer treatment","volume":"151","author":"Bhagyalalitha","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jconrel.2026.115009_bb0125","article-title":"Targeted nanoparticle for co-delivery of HER2 siRNA and a taxane to mirror the standard treatment of HER2+ breast cancer: efficacy in breast tumor and brain metastasis","volume":"18","author":"Ngamcherdtrakul","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.115009_bb0130","article-title":"Surface engineering Salmonella with pH-responsive polyserotonin and self-activated DNAzyme for better microbial therapy of tumor","volume":"3","author":"Guo","year":"2023","journal-title":"Exploration"},{"key":"10.1016\/j.jconrel.2026.115009_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101722","article-title":"Reversing the negative effect of adenosine A1 receptor-targeted immunometabolism modulation on melanoma by a co-delivery nanomedicine for self-activation of anti-PD-L1 DNAzyme","volume":"48","author":"Guo","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.115009_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202270044","article-title":"Anti-PD-L1 DNAzyme loaded photothermal Mn(2+) \/Fe(3+) hybrid metal-phenolic networks for cyclically amplified tumor ferroptosis-immunotherapy","volume":"11","author":"Liu","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.115009_bb0145","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/thno.17736","article-title":"Theranostic DNAzymes","volume":"7","author":"Zhou","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115009_bb0150","doi-asserted-by":"crossref","first-page":"10882","DOI":"10.1039\/D3NR00425B","article-title":"DNA hydrogels and nanogels for diagnostics, therapeutics, and theragnostics of various cancers","volume":"15","author":"Zare","year":"2023","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.115009_bb0155","doi-asserted-by":"crossref","first-page":"16407","DOI":"10.1039\/D3CP04131J","article-title":"Bonding states of gold\/silver plasmonic nanostructures and sulfur-containing active biological ingredients in biomedical applications: a review","volume":"26","author":"Esmailzadeh","year":"2024","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jconrel.2026.115009_bb0160","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41556-019-0352-z","article-title":"HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity","volume":"21","author":"Wu","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0165","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature23890","article-title":"cGAS senses long and HMGB\/TFAM-bound U-turn DNA by forming protein-DNA ladders","volume":"549","author":"Andreeva","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115009_bb0170","article-title":"Mitigating doxorubicin-induced cardiotoxicity and enhancing anti-tumor efficacy with a metformin-integrated self-assembled nanomedicine","volume":"12","author":"Huang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.115009_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108053","article-title":"Mn(2+) directly activates cGAS and structural analysis suggests Mn(2+) induces a noncanonical catalytic synthesis of 2\u20323'-cGAMP","volume":"32","author":"Zhao","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.115009_bb0180","article-title":"Mn-phenolic networks as synergistic carrier for STING agonists in tumor immunotherapy","volume":"26","author":"Meng","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115009_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jcis.2023.01.089","article-title":"Poly-thymine DNA templated MnO(2) biomineralization as a high-affinity anchoring enabling tumor targeting delivery","volume":"637","author":"Meng","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.115009_bb0195","doi-asserted-by":"crossref","first-page":"10504","DOI":"10.1021\/jacs.4c18511","article-title":"Manganese-driven plasmid nanofibers formed in situ for cancer gene delivery and metalloimmunotherapy","volume":"147","author":"Li","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115009_bb0200","article-title":"Understanding of endo\/lysosomal escape of nanomaterials in biomedical application","volume":"3","author":"Wang","year":"2025","journal-title":"Smart Mol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.apsb.2020.07.021","article-title":"A smart MnO(2)-doped graphene oxide nanosheet for enhanced chemo-photodynamic combinatorial therapy via simultaneous oxygenation and glutathione depletion","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115009_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119513","article-title":"Metal organic framework coated MnO(2) nanosheets delivering doxorubicin and self-activated DNAzyme for chemo-gene combinatorial treatment of cancer","volume":"585","author":"Nie","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115009_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexmp.2009.05.001","article-title":"The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies","volume":"87","author":"Freudenberg","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.jconrel.2026.115009_bb0220","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12964-024-02000-2","article-title":"Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4","volume":"22","author":"Wang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2026.115009_bb0225","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.3390\/nu16213653","article-title":"Effect of whole blood dietary mineral concentrations on erythrocytes: selenium, manganese, and chromium: NHANES data","volume":"16","author":"Costa","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.jconrel.2026.115009_bb0230","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/toxsci\/kfn213","article-title":"Manganese induces dopaminergic neurodegeneration via microglial activation in a rat model of manganism","volume":"107","author":"Zhao","year":"2009","journal-title":"Toxicol. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:23:21Z","timestamp":1783049001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":46,"alternative-id":["S0168365926004128"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breaking the oncogene\u2013immune suppression cycle through dual HER2 silencing and innate immune activation by biomineralized DNA nanocomplexes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115009"}}